To get Mounjaro you need a prescription, and it is FDA-approved for type 2 diabetes, so insurance commonly covers it for diabetes but rarely for weight loss, where Zepbound is the on-label brand. As of October 2026, covered commercial patients can pay $25, and Lilly sells it self-pay for $499 a month.
Getting Mounjaro comes down to a fact the ads gloss over: Mounjaro is a diabetes drug.The exact same medicine, aimed at weight loss, is sold under a different name — Zepbound. So “how do I get Mounjaro?” is really two questions wearing one coat, and which one you’re asking decides your whole route.
One molecule, two brands
Mounjaro (tirzepatide) was FDA-approved in 2022 to improve blood sugar in adults with type-2 diabetes.[1] The identical molecule was later approved for chronic weight management under the name Zepbound.[1] Same drug, same maker (Eli Lilly), two brands for two indications. That matters because insurance, savings programs and cash options all key off which brand and which purpose — not the molecule.
| Your reason | The realistic route |
|---|---|
| Type-2 diabetes | On-label Mounjaro — doctor prescribes, insurance often covers |
| Weight loss, no diabetes | Off-label Mounjaro is usually uncovered — Zepbound is the on-label route |
| Paying cash | LillyDirect sells both: Mounjaro $499/mo at every dose; Zepbound $299–$449/mo |
How do you get Mounjaro if you have type 2 diabetes?
Straightforward: a primary-care doctor or endocrinologist confirms type-2 diabetes and can prescribe Mounjaro on-label. Used for its approved purpose, commercial plans and Medicare Part D commonly cover it, subject to formulary tier and prior authorization.[2] If your commercial plan covers it, Lilly’s savings card can bring the copay to as little as $25 for up to a 3-month prescription.[2]
Can you get Mounjaro for weight loss?
A clinician can prescribe Mounjaro off-label for weight loss, but insurance generally won’t cover Mounjaro for weight loss, and the savings card is tied to the diabetes indication. The on-label answer is Zepbound — same tirzepatide, approved for obesity, with a cash self-pay price of $299–$449/month by dose (vial or KwikPen) for people without coverage, below Mounjaro’s $499 self-pay price at every dose if you refill within 45 days.[3] See our Mounjaro vs Zepbound comparison and the Zepbound cost guide.
How much does Mounjaro cost?
Mounjaro’s list price (WAC) is $1,112.16 per fill.[4] Few pay that: a covered commercial plan plus the savings card lands near $25; a commercial plan that doesn’t cover it routes you to about $499/month via the card;[2] and uninsured patients can buy Mounjaro pens directly from Lilly through LillyDirect at $499 a month at every dose (October 2026).[6] Model the scenarios in our GLP-1 cost estimator.
What about compounded Mounjaro?
Compounded tirzepatide was a cheap shortage-era workaround that has largely ended. Tirzepatide came off the FDA shortage list in late 2024, closing the mass compounding exemption. In February 2026 the FDA announced it intends to restrict GLP-1 ingredients meant for mass-marketed, non-approved compounded copies, and on April 30, 2026 it proposed excluding tirzepatide from the bulk substances outsourcing facilities may compound; the extended comment period closed July 30, 2026, and no final decision had been announced as of October 2026.[5] A cheap “compounded Mounjaro” subscription is no longer a reliable or clearly-legal route — see our compounded vs branded guide.
The honest bottom line
Have type-2 diabetes? Getting Mounjaro is the easy, often-covered path — confirm the diagnosis and use the savings card if you’re commercially insured.[2] Want it for weight loss? The real answer is Zepbound, the on-label, self-pay-friendly version of the same molecule. Either way, compare the legitimate telehealth routes in our best GLP-1 providers roundup, and ground your decision in our tirzepatide evidence guide.